Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by GrahamBon Nov 01, 2022 9:44am
122 Views
Post# 35062604

RE:RE:RE:RE:Sold it all

RE:RE:RE:RE:Sold it all
theNorm wrote:
Wars over buddy, you lost. Being recommend by NICE means VPT is now the standard of care for cardiac patients in the UK replacing expensive MRI imaging. It's all explained at ceo ca




As I said to Norm at the time. His statemnet was not based in fact.
I indicated I believed VPT would not recieve a positive review based on limited studies.

The result is:


"Key uncertainties around the evidence or technology are that only 1 study was done in the UK and is generalisable to the NHS, and there is limited evidence assessing left ventricular and atrial volumes. One study also found that agreement between VMS+ and cardiac MRI was unsatisfactory for measuring right ventricle ejection fraction. • Experts advised that more evidence is needed before VMS+ can be routinely used in the NHS. Experts disagreed about where VMS+ would provide the most benefit in the care pathway. One expert felt that VMS+ would provide little additional value than existing technologies."


Just saying do your own DD-dont invest based on what anyone says here, especially me. 
Caveat Emptor.
<< Previous
Bullboard Posts
Next >>